查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1636769

2030 年消費者基因體學市場預測：按測試類型、技術、分銷管道、應用、最終用戶和地區進行的全球分析

Consumer Genomics Market Forecasts to 2030 - Global Analysis By Test Type (Health Risk Testing, Traits Testing, Carrier Screening and Pharmacogenomics), Technology, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球消費者基因組學市場預計在 2024 年達到 19.7 億美元，到 2030 年將達到 82.1 億美元，預測期內的複合年成長率為 26.8%。

消費者基因體學是基因體學的一個分支，直接向個人提供基因檢測服務，讓他們探索自己的 DNA，了解自己的祖先、健康、保健和個人特徵。這使消費者能夠最佳化他們的生活方式選擇，客製化他們的醫療保健，並了解他們的疾病遺傳傾向。消費者基因組學利用次世代定序和基因型鑒定等最尖端科技，使基因資訊更容易取得且價格更實惠。直接面對消費者的平台正在透過改變個人醫療保健和增加有關遺傳影響的了解來幫助擴大該行業的知名度。

根據國際癌症研究機構（IARC）的數據，到 2040 年未確診的癌症病例數預計將達到 3,020 萬人。

人們對血統和遺傳遺產的興趣日益濃厚

人們對遺傳遺產和祖先的興趣日益濃厚，對消費者基因組學領域產生了重大影響。隨著人們想要更多地了解自己的祖先和種族背景，DNA檢測套組的需求量很大。許多變數促成了這一趨勢，包括廣泛的行銷和直接面對消費者的測試服務。由於許多消費者渴望了解更多資訊並與祖先建立聯繫，因此進行的測試數量創下了歷史新高。 23andMe 和 Ancestry 等公司透過建立龐大的資料庫從這項興趣中獲利，這些資料庫使得基因檢測對祖先研究和個人發現更有吸引力。

技術和資料整合挑戰

測試程序缺乏標準化是一個重大問題，可能導致多個操作員的結果不一致。此外，缺乏法律規範可能會使人們對基因資料解釋的可靠性和正確性產生懷疑，從而削弱客戶信任。關鍵問題包括資料安全和隱私。由於擔心濫用和未授權存取，人們越來越擔心自己的基因資料的收集、儲存和使用。解決這些問題對於建立信任和確保長期市場成長至關重要。

擴大醫療保健和健康服務

基因組學的發展使人們能夠了解自己對各種疾病的遺傳易感性的資訊，從而實現早期發現和主動的健康管理。各種健康公司正在利用基因資料提供個人化的健身、飲食和生活方式提案，以改善整體健康。此外，藥物基因體學，即利用基因資訊定製藥物治療，正被用於最大限度地提高治療效果和最大限度地減少副作用。隨著越來越多的健康計劃和醫療保健專業人員利用基因技術，消費者基因組學市場正在擴大，從而提高了個人化健康解決方案的有效性和可及性。

隱私和資料安全問題

由於資料外洩、未授權存取和濫用的風險，消費者通常不願意向公司提供他們的 DNA 資訊。隨著線上基因檢測平台越來越受歡迎，基因資料的儲存和交換引發了人們對個人資料安全的嚴重擔憂。這些擔憂因基因資訊可能被用於歧視目的而加劇，包括在保險和職場。因此，強而有力的資料保護政策、透明的同意程序和法規合規性對於贏得客戶信任和確保市場擴張至關重要。

COVID-19 的影響

COVID-19 疫情對消費者基因組學市場產生了多方面的影響。一方面，隨著消費者尋求更好地了解自己患有包括新冠肺炎在內的疾病的遺傳風險的方法，疫情增加了人們對個人健康、保健和基因檢測的關注。另一方面，物流挑戰、測試處理延遲和供應鏈中斷暫時影響了市場。然而，家庭健康檢測需求的不斷成長和向數位化醫療的轉變促進了消費者基因組學市場的長期成長。

預測期內，基因型鑒定型市場預計將成為最大的市場

由於次世代定序（NGS）的出現使得基因檢測更加容易獲得、更實惠、更準確，從而促進了其廣泛應用，因此基因型鑒定領域估計將是最大的領域。此外，消費者越來越尋求個人化的健康見解來主動管理他們的健康，從而導致對基因檢測服務的需求激增。數位健康技術的融合進一步推動了這一趨勢，這些技術增強了基因組資料的分析和應用，使個人能夠做出明智的生活方式和醫療保健決策。

預計預測期內醫療保健提供者部門將以最高的複合年成長率成長。

由於對個人化醫療的日益重視和對預防性醫療保健解決方案的需求不斷成長，預計醫療保健提供者部門將在預測期內實現最高的複合年成長率。隨著醫療保健專業人員意識到基因洞察的價值，他們正在將基因組資訊整合到患者護理中，以客製化治療並改善健康結果。消費者對基因對健康影響的認知不斷提高，這鼓勵了供應商提供基因檢測服務。此外，基因組學技術的進步和法律規範正在促進醫療保健提供者和基因組學相關企業之間的合作，進一步推動市場成長。

佔比最大的地區：

由於醫療保健支出的增加、慢性病盛行率的上升以及對個人化醫療的認知的不斷提高，預計亞太地區將在預測期內佔據最大的市場佔有率。此外，次世代定序（NGS）等基因組技術的進步使得基因檢測更便宜、更容易取得。此外，該地區的智慧型手機普及率和網路普及率正在不斷提高，這推動了直接面對消費者 (DTC) 的基因檢測服務的成長。

複合年成長率最高的地區：

預計北美地區在預測期內的複合年成長率最高。這是由於消費者對個人化醫療意識的不斷增強、對家庭基因檢測的需求不斷增加以及基因組技術的進步。該地區受益於發達的醫療保健基礎設施、便利的基因檢測服務和高可支配收入。此外，北美對基因檢測和資料隱私法有強而有力的監管支持，進一步鼓勵消費者參與。智慧醫療保健和健康趨勢的興起也推動了該地區的市場成長。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業進行基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球消費者基因體學市場（依測試類型）

  • 健康風險測試
  • 特性測試
  • 攜帶者篩檢
  • 藥物基因組學

6. 全球消費者基因體學市場（依技術分類）

  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 微陣列
  • 基於 CRISPR 的技術
  • 核酸萃取與精製
  • 基因型鑒定
  • 其他技術

7. 全球消費者基因體學市場按分銷管道分類

  • 零售商
  • 網路平台
  • 醫療設施

8. 全球消費者基因體學市場（按應用）

  • 血統和種族測試
  • 健康與保健
  • 個人化醫療
  • 遺傳相關性
  • 診斷
  • 生活方式、健康與營養
  • 生殖健康
  • 運動營養與健康
  • 其他用途

9. 全球消費者基因體學市場（依最終用戶分類）

  • 製藥公司
  • 醫療保健提供者
  • 研究所
  • 個人消費者
  • 其他最終用戶

第 10 章。

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Ancestry.com LLC
  • MyHeritage Ltd.
  • Helix OpCo LLC
  • Living DNA Ltd.
  • Veritas Genetics
  • Mapmygenome India Ltd.
  • Pathway Genomics Corporation
  • Color Genomics, Inc.
  • Invitae Corporation
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Fulgent Genetics, Inc.
  • Nebula Genomics
  • Orig3n, Inc.
  • EasyDNA
  • TellmeGen
  • Genetic Technologies Limited
Product Code: SMRC28411

According to Stratistics MRC, the Global Consumer Genomics Market is accounted for $1.97 billion in 2024 and is expected to reach $8.21 billion by 2030 growing at a CAGR of 26.8% during the forecast period. Consumer genomics refers to the branch of genomics that provides genetic testing services directly to individuals, enabling them to explore their DNA for insights into ancestry, health, wellness, and personal traits. It enables consumers to optimize lifestyle choices, customize healthcare, and comprehend genetic predispositions to diseases. Consumer genomics provides easily available and reasonably priced genetic information by leveraging cutting-edge technology such as next-generation sequencing and genotyping. Direct-to-consumer platforms have helped this industry grow in popularity by transforming personal healthcare and raising knowledge of genetic influences.

According to the International Agency for Research on Cancer (IARC), the number of un-diagnosed cancer cases is expected to reach 30.2 MN, by 2040.

Market Dynamics:

Driver:

Increased interest in ancestry and genetic heritage

Growing interest in genetic heritage and ancestry is having a big impact on the consumer genomics sector. DNA testing kits are in high demand as people try to learn more about their ancestry and ethnic backgrounds. Numerous variables, such as extensive marketing and the availability of direct-to-consumer testing services, are contributing to this trend. A record number of tests are being undertaken because many consumers are driven by a desire to learn more about their ancestry and connect with their ancestors. Businesses such as 23andMe and Ancestry have benefited from this interest by building extensive databases that increase the allure of genetic testing for ancestry research and personal discovery.

Restraint:

Technological and data integration challenges

Lack of standardization in testing procedures is a significant problem that can provide inconsistent outcomes across several businesses. Furthermore, the lack of regulatory supervision casts doubt on the dependability and correctness of interpreting genetic data, which could erode customer confidence. Critical issues include data security and privacy; people are growing more concerned about the collection, storage, and use of their genetic data out of concern about abuse or illegal access. Resolving these issues is crucial to building trust and guaranteeing the market's long-term growth.

Opportunity:

Expansion of healthcare and wellness services

The development of genomics has given people access to information about their genetic susceptibilities to various illnesses, enabling early disease detection and proactive health management. In order to improve overall health results, a variety of wellness companies are using genetic data to provide individualized fitness, food, and lifestyle recommendations. Additionally, pharmacogenomics the customization of pharmaceutical therapies using genetic information is being employed to maximize therapeutic efficacy and minimize side responses. The market for consumer genomics is growing as more wellness programs and healthcare professionals use genetics, increasing the effectiveness and accessibility of personalized health solutions.

Threat:

Privacy and data security concerns

Consumers are frequently hesitant to give businesses their DNA information because of the possible dangers of data breaches, illegal access, and abuse. With the growing popularity of online genetic testing platforms, the storage and exchange of genetic data raises serious concerns regarding the security of personal data. These worries are further heightened by the possibility that genetic information would be utilized for discriminatory purposes, including in insurance or the workplace. Therefore, it is essential to have strong data protection policies, transparent consent procedures, and regulatory compliance in order to gain the trust of customers and guarantee market expansion

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the consumer genomics market. On one hand, the pandemic led to an increased focus on personal health, wellness, and genetic testing as consumers sought ways to better understand their genetic risks for diseases, including COVID-19. On the other hand, logistical challenges, delays in test processing, and disruptions in supply chains temporarily affected the market. However, the growing demand for at-home health testing and the shift to digital healthcare contributed to the long-term growth of the consumer genomics market.

The genotyping segment is expected to be the largest during the forecast period

The genotyping segment is estimated to be the largest, due to the emergence of next-generation sequencing (NGS) has made genetic testing more accessible, affordable, and accurate, facilitating widespread adoption. Additionally, consumers are increasingly seeking personalized health insights to manage their well-being proactively, leading to a surge in demand for genetic testing services. This trend is further supported by the integration of digital health technologies, which enhance the analysis and application of genomic data, empowering individuals to make informed lifestyle and healthcare decisions.

The healthcare providers segment is expected to have the highest CAGR during the forecast period

The healthcare providers segment is anticipated to witness the highest CAGR during the forecast period, due to the rising emphasis on personalized medicine and the increasing demand for preventive healthcare solutions. As healthcare professionals recognize the value of genetic insights, they are integrating genomic information into patient care to tailor treatments and improve health outcomes. The growing awareness among consumers about the influence of genetics on health is prompting providers to offer genetic testing services. Additionally, advancements in genomic technologies and supportive regulatory frameworks are facilitating collaborations between healthcare providers and genomics companies, further driving market growth.

Region with largest share:

Asia Pacific is expected to have the largest market share during the forecast period due to increasing healthcare expenditure, rising prevalence of chronic diseases, and growing awareness of personalized medicine. Additionally, advancements in genomic technologies, such as next-generation sequencing (NGS), are making genetic testing more affordable and accessible. Furthermore, the increasing adoption of smartphones and internet penetration in the region is facilitating the growth of direct-to-consumer (DTC) genetic testing services.

Region with highest CAGR:

During the forecast period, the North America region is anticipated to register the highest CAGR, owing to rising consumer awareness of personalized healthcare, growing demand for at-home genetic testing, and advancements in genomic technologies. The region benefits from a well-established healthcare infrastructure, with easy access to genetic testing services and a high level of disposable income. Additionally, North America sees strong regulatory support for genetic research and data privacy laws, further encouraging consumer participation. The widespread adoption of smart healthcare and wellness trends also propels market growth in the region.

Key players in the market

Some of the key players profiled in the Consumer Genomics Market include Ancestry.com LLC, MyHeritage Ltd., Helix OpCo LLC, Living DNA Ltd., Veritas Genetics, Mapmygenome India Ltd., Pathway Genomics Corporation, Color Genomics, Inc., Invitae Corporation, Thermo Fisher Scientific Inc., Illumina, Inc., Fulgent Genetics, Inc., Nebula Genomics, Orig3n, Inc., EasyDNA, TellmeGen, and Genetic Technologies Limited.

Key Developments:

In July 2024, Ancestry Launches NEW Interactive DNA Compare Experience to Help Fans Discover How Their DNA Compares to More Than 15 World-Class Athletes.

In December 2023, Helix and Sanford Health Partner on 100K Population Genomics Health Initiative in Upper Midwest. Genomics company Helix and healthcare system Sanford Health announced a population genomics partnership to bring precision medicine to rural communities in the Upper Midwest.

Test Types Covered:

  • Health Risk Testing
  • Traits Testing
  • Carrier Screening
  • Pharmacogenomics

Technologies Covered:

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • CRISPR-based Technologies
  • Nucleic Acid Extraction and Purification
  • Genotyping
  • Other Technologies

Distribution Channels Covered:

  • Retail Stores
  • Online Platforms
  • Healthcare Facilities

Applications Covered:

  • Ancestry & Ethnicity Testing
  • Health & Wellness
  • Personalized Medicine
  • Genetic Relatedness
  • Diagnostics
  • Lifestyle, Wellness, and Nutrition
  • Reproductive Health
  • Sports Nutrition and Health
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Healthcare Providers
  • Research Institutions
  • Individual Consumers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Consumer Genomics Market, By Test Type

  • 5.1 Introduction
  • 5.2 Health Risk Testing
  • 5.3 Traits Testing
  • 5.4 Carrier Screening
  • 5.5 Pharmacogenomics

6 Global Consumer Genomics Market, By Technology

  • 6.1 Introduction
  • 6.2 Next-Generation Sequencing (NGS)
  • 6.3 Polymerase Chain Reaction (PCR)
  • 6.4 Microarray
  • 6.5 CRISPR-based Technologies
  • 6.6 Nucleic Acid Extraction and Purification
  • 6.7 Genotyping
  • 6.8 Other Technologies

7 Global Consumer Genomics Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Stores
  • 7.3 Online Platforms
  • 7.4 Healthcare Facilities

8 Global Consumer Genomics Market, By Application

  • 8.1 Introduction
  • 8.2 Ancestry & Ethnicity Testing
  • 8.3 Health & Wellness
  • 8.4 Personalized Medicine
  • 8.5 Genetic Relatedness
  • 8.6 Diagnostics
  • 8.7 Lifestyle, Wellness, and Nutrition
  • 8.8 Reproductive Health
  • 8.9 Sports Nutrition and Health
  • 8.10 Other Applications

9 Global Consumer Genomics Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Companies
  • 9.3 Healthcare Providers
  • 9.4 Research Institutions
  • 9.5 Individual Consumers
  • 9.6 Other End Users

10 Global Consumer Genomics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Ancestry.com LLC
  • 12.2 MyHeritage Ltd.
  • 12.3 Helix OpCo LLC
  • 12.4 Living DNA Ltd.
  • 12.5 Veritas Genetics
  • 12.6 Mapmygenome India Ltd.
  • 12.7 Pathway Genomics Corporation
  • 12.8 Color Genomics, Inc.
  • 12.9 Invitae Corporation
  • 12.10 Thermo Fisher Scientific Inc.
  • 12.11 Illumina, Inc.
  • 12.12 Fulgent Genetics, Inc.
  • 12.13 Nebula Genomics
  • 12.14 Orig3n, Inc.
  • 12.15 EasyDNA
  • 12.16 TellmeGen
  • 12.17 Genetic Technologies Limited

List of Tables

  • Table 1 Global Consumer Genomics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Consumer Genomics Market Outlook, By Test Type (2022-2030) ($MN)
  • Table 3 Global Consumer Genomics Market Outlook, By Health Risk Testing (2022-2030) ($MN)
  • Table 4 Global Consumer Genomics Market Outlook, By Traits Testing (2022-2030) ($MN)
  • Table 5 Global Consumer Genomics Market Outlook, By Carrier Screening (2022-2030) ($MN)
  • Table 6 Global Consumer Genomics Market Outlook, By Pharmacogenomics (2022-2030) ($MN)
  • Table 7 Global Consumer Genomics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 8 Global Consumer Genomics Market Outlook, By Next-Generation Sequencing (NGS) (2022-2030) ($MN)
  • Table 9 Global Consumer Genomics Market Outlook, By Polymerase Chain Reaction (PCR) (2022-2030) ($MN)
  • Table 10 Global Consumer Genomics Market Outlook, By Microarray (2022-2030) ($MN)
  • Table 11 Global Consumer Genomics Market Outlook, By CRISPR-based Technologies (2022-2030) ($MN)
  • Table 12 Global Consumer Genomics Market Outlook, By Nucleic Acid Extraction and Purification (2022-2030) ($MN)
  • Table 13 Global Consumer Genomics Market Outlook, By Genotyping (2022-2030) ($MN)
  • Table 14 Global Consumer Genomics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 15 Global Consumer Genomics Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 16 Global Consumer Genomics Market Outlook, By Retail Stores (2022-2030) ($MN)
  • Table 17 Global Consumer Genomics Market Outlook, By Online Platforms (2022-2030) ($MN)
  • Table 18 Global Consumer Genomics Market Outlook, By Healthcare Facilities (2022-2030) ($MN)
  • Table 19 Global Consumer Genomics Market Outlook, By Application (2022-2030) ($MN)
  • Table 20 Global Consumer Genomics Market Outlook, By Ancestry & Ethnicity Testing (2022-2030) ($MN)
  • Table 21 Global Consumer Genomics Market Outlook, By Health & Wellness (2022-2030) ($MN)
  • Table 22 Global Consumer Genomics Market Outlook, By Personalized Medicine (2022-2030) ($MN)
  • Table 23 Global Consumer Genomics Market Outlook, By Genetic Relatedness (2022-2030) ($MN)
  • Table 24 Global Consumer Genomics Market Outlook, By Diagnostics (2022-2030) ($MN)
  • Table 25 Global Consumer Genomics Market Outlook, By Lifestyle, Wellness, and Nutrition (2022-2030) ($MN)
  • Table 26 Global Consumer Genomics Market Outlook, By Reproductive Health (2022-2030) ($MN)
  • Table 27 Global Consumer Genomics Market Outlook, By Sports Nutrition and Health (2022-2030) ($MN)
  • Table 28 Global Consumer Genomics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 29 Global Consumer Genomics Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 Global Consumer Genomics Market Outlook, By Pharmaceutical Companies (2022-2030) ($MN)
  • Table 31 Global Consumer Genomics Market Outlook, By Healthcare Providers (2022-2030) ($MN)
  • Table 32 Global Consumer Genomics Market Outlook, By Research Institutions (2022-2030) ($MN)
  • Table 33 Global Consumer Genomics Market Outlook, By Individual Consumers (2022-2030) ($MN)
  • Table 34 Global Consumer Genomics Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.